← Back to Analyst Consensus 
ITRM Hold
Iterum Therapeutics plc
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 30, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Aug 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Jun 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| May 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Apr 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Apr 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Mar 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Feb 7, 2024 | HC Wainwright & Co. | upgrade | Neutral → Buy | $6 | 44% |
EPS Estimates
+1q —
+1y $-0.24
Lo: $-0.24 Hi: $-0.24
1 analysts 0y $-0.73
Lo: $-0.73 Hi: $-0.73
1 analysts 0q $-0.20
Lo: $-0.20 Hi: $-0.20
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days